Cancer Genomics - Proteomics: 4 (2)

March-April 2007; Volume 4,Issue 2

You have access
Discovery of Oral Fluid Biomarkers for Human Oral Cancer by Mass Spectrometry
SHEN HU, TIANWEI YU, YONGMING XIE, YANAN YANG, YANG LI, XIAOFENG ZHOU, STEPHANIE TSUNG, RACHEL R. LOO, JOSEPH A. LOO and DAVID T. WONG

Cancer Genomics & Proteomics March 2007, 4 (2) 55-64;
You have access
Immunogenic Chemotherapy: Discovery of a Critical Protein through Proteomic Analyses of Tumor Cells
LIONEL APETOH, MICHEL OBEID, ANTOINE TESNIERE, FRANÇOIS GHIRINGHELLI, GIAN MARIA FIMIA, MAURO PIACENTINI, GUIDO KROEMER and LAURENCE ZITVOGEL

Cancer Genomics & Proteomics March 2007, 4 (2) 65-70;
You have access
The N-terminal 15-48 Region of Cyclin Kinase Inhibitor p21 is a Determinant of Basal Expression
NORIHIRO NOMURA, FUMIHIRO YAMAGUCHI and KUNIHIKO FUKUCHI

Cancer Genomics & Proteomics March 2007, 4 (2) 71-80;
You have access
Pharmacogenomics of a Traditional Japanese Herbal Medicine (Kampo) for Cancer Therapy
THOMAS EFFERTH, HAYATO MIYACHI and HELMUT BARTSCH

Cancer Genomics & Proteomics March 2007, 4 (2) 81-91;
You have access
Diallyl Disulfide Induced Signal Transducer and Activator of Transcription 1 Expression in Human Colon Cancer Colo 205 Cells using Differential Display RT-PCR
HSU-FUNG LU, JAI-SING YANG, YUH-TZY LIN, TZU-WEI TAN, SIU-WAN IP, YU-CHING LI, MEI-FEN TSOU and JING-GUNG CHUNG

Cancer Genomics & Proteomics March 2007, 4 (2) 93-97;
You have access
DNA Damage Response: The Players, the Network and the Role in Tumor Suppression
REKHA RAI, GUANG PENG, KAIYI LI and SHIAW-YIH LIN

Cancer Genomics & Proteomics March 2007, 4 (2) 99-106;

Main menu

User menu

Search

Table of Contents

In this issue